CeriBell, Inc.

NASDAQ:CBLL

Medical - Devices

Healthcare
$25.63 +1.42%

+$0.25 today

Market cap
$995.34M
Beta
0.84
P/E (TTM)
-10.9
EPS (TTM)
-$1.60
52W Low $10.85High $24.33

Volume 0.41M

Average 0.29M

CBLL Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

CeriBell, Inc.NASDAQ: CBLL

Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Investing cash flow turns positive

Q1 FY2026 investing cash flow was $22.44M, compared with -$29.61M a year earlier. Trailing-twelve-month investing cash flow was -$66.09M. Over 3 fiscal years it compounded at +338.7% a year.

Context

  • Investing cash flow amounted to 132.6% of revenue in FY2025, up 130.2 pp from a year earlier.
  • Investing cash flow grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly investing cash flow holds near $22.44M or moves back toward the trailing-twelve-month quarterly average of -$16.52M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$22.44M-14.0% QoQ
Last fiscal yearDec 2025
-$118.14M+7292.8% YoY
LTMMar 2026
-$66.09M+112.7% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+175.8%——
1 year+7292.8%——
3-year CAGR+338.7%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
(118.14M) USD
Year-over-year change
-7292.8%

Investing Cash Flow vs competitors

How CBLL compares with its peers on the latest reported figures

  • CBLL's LTM Mar 2026 investing cash flow of $66.09M is the 2nd largest of the 7 companies compared; the peer median is $670.5K.
  • Its year-over-year change of +112.7% is the highest of 7, against a peer median of -85.7%.
  • Investing cash flow amounts to 69.5% of revenue for CBLL, versus a peer median of 0.7%.
CBLL Competitors Peer median
Investing Cash Flow for CBLL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LIVNLivaNova PLCLTM Sep 2026$99.76M +86.9%+23.8%6.6%
CBLLCeriBell, Inc.LTM Mar 2026$66.09M +112.7%+338.7%69.5%
BWAYBrainsWay Ltd.LTM Mar 2026$24.87M -185.6%—44.2%
STIMNeuronetics, Inc.LTM Mar 2026$753K -72.1%—0.5%
CVRXCVRx, Inc.LTM Mar 2026$588K +5.4%-5.4%1.0%
NPCENeuroPace, Inc.LTM Mar 2026$412K -106.3%—0.4%
ECORelectroCore, Inc.LTM Mar 2026$26K -99.4%—0.1%
Peer median (excluding CBLL) $670.5K-85.7%+9.2%0.7%

Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(37.16M)(29.46M)(40.46M)(53.41M)
Depreciation & Amortization497K847K1.14M(670K)
Deferred Income Tax0000
Stock-Based Compensation7.93M2.68M5.41M12.22M
Change in Working Capital(3.88M)(3.7M)(3.17M)633K
Accounts Receivables(3.96M)(3.43M)(3.51M)(4.18M)
Inventory(1.9M)(1.79M)(1.07M)(351K)
Accounts Payables124K309K250K1.75M
Other Working Capital1.85M1.22M1.16M3.41M
Other Non-Cash Items621K477K2.03M418K
Operating Cash Flow(32M)(29.16M)(35.04M)(40.81M)
Capital Expenditures(516K)(983K)(1.34M)(767K)
Acquisitions (Net)0000
Purchases of Investments000(210.82M)
Sales of Investments00094.2M
Other Investing Activities(883K)(780K)(258K)(755K)
Investing Cash Flow(1.4M)(1.76M)(1.6M)(118.14M)
Debt Repayment(39K)(3.75M)7.91M0
Common Stock Issued00188.92M5.44M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities154K932K(304K)(386K)
Financing Cash Flow49.81M(2.82M)196.52M5.05M
Effect of Forex Changes0000
Net Change in Cash16.4M(33.74M)159.88M(153.89M)
Free Cash Flow(32.52M)(30.14M)(36.38M)(41.58M)

CeriBell, Inc.

NASDAQ:CBLL

Intrinsic Alpha fair value

Locked

Current Price

$25.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.